Ignite SD
0
Login
Register
Viewing StudyNCT00045526
Home
Search
Stocks
Certify Doc
Genes
Clinical Trials
CompTox
DrugMatrix
Open Targets
Products
Support
Bugs
eRecord
Main Search
All Studies
All Organizations
Report Bug
View Study With Definitions
Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00045526
Status:
COMPLETED
Last Update Posted:
2013-06-04
First Post:
2002-09-06
Brief Title:
Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Overview
Dates
Organization
Conditions
Design
Enrollment
Locations
Outcomes
Conditions & Keywords Data
Conditions:
Name
Stage IV Esophageal Cancer
Adenocarcinoma of the Esophagus
Adenocarcinoma of the Gastroesophageal Junction
Recurrent Esophageal Cancer
Squamous Cell Carcinoma of the Esophagus
Stage III Esophageal Cancer
Keywords: